September 25, 2015
Daiichi Sankyo said on September 24 that the British National Institute for Health and Care Excellence (NICE) has recommended health coverage for its anticoagulant Lixiana (edoxaban) for the prevention of stroke and systemic embolism (SE) in adult patients with non-valvular...read more